Information  X 
Enter a valid email address



Wednesday 01 December, 2021


Notice of Intended Substitution

RNS Number : 1892U
01 December 2021

Notice of Intended Substitution of
in place of MDGH - GMTN B.V.
as Issuer of the

GBP550,000,000 6.875 per cent. Notes due 2026 (XS0605560084)

U.S.$1,500,000,000 5.500 per cent. Notes due 2022 (XS0701035676 and US44985GAD34)

U.S.$750,000,000 6.875 per cent. Notes due 2041 (XS0701227075 and US44985GAE17)

EUR850,000,000 3.625 per cent. Notes due 2023 (XS0860584308)

(together, the Notes)

1 December 2021. NOTICE IS HEREBY GIVEN of the intended substitution of MDGH GMTN (RSC) Ltd in place of MDGH - GMTN B.V. as Issuer of the Notes pursuant to Condition 11(c) of the relevant Notes. Subject to the requirements set out in paragraphs (i) - (vi) of Condition 11(c) of the relevant Notes having been satisfied, with effect from and including 22 December 2021, all rights, obligations and liabilities of MDGH - GMTN B.V. under or pursuant to the Notes listed above will be assumed by MDGH GMTN (RSC) Ltd as if it had been the original Issuer of such Notes.

Copies of the Substitution Deed Poll and the legal opinions required to be delivered pursuant to the requirements set out in Condition 11(c) of the Notes shall be available for inspection at the specified office of each Paying Agent.

Capitalised terms used but not defined in this notice shall have the same meanings given to such terms in the Conditions of the relevant Notes.

This Notice is given by MDGH GMTN (RSC) Ltd.

Dated: 1 December 2021



For further information, please contact:


Mamoura Diversified Global Holding PJSC

P.O. Box 45005, Abu Dhabi, United Arab Emirates



+971 2 413 0000


+971 2 413 0001


[email protected] (for investor relations queries) [email protected] (for media queries)


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t